Image-guided Drug Delivery (R01)
Deadline: June 21, 2018; November 22, 2018
Amount: Not limited but must reflect the actual needs of the proposed project; maximum project period is 5 years
To support innovative research in image-guided drug delivery (IGDD) for cancer and other diseases. The overarching goals of this FOA are to support the development of quantitative in vivo imaging methods for IGDD to guide, monitor, and evaluate drug delivery across different physical and physiological scales in order to interrogate biodistribution and target-drug interaction (pharmacokinetics and pharmacodynamics) and therapeutic response. Studies that are directed towards translation of IGDD technology to patient care are considered appropriate for this FOA.